
Senmag Cell And Gene Therapy Private Limited
Develops CAR T-cell therapy, gene therapy, and cell-based treatments.
Develops CAR T-cell therapy, gene therapy, and cell-based treatments.
Chennai, Tamil Nadu, India
+91-XXXXXXXXXX
U85100TN2019PTC133247
133247
Private Limited Indian Non-Government Company
17 Dec 2019
-
-
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Senthil Ganesan ![]() | Director | 17-Dec-2019 | Current |
Subramanian Ganesan ![]() | Director | 17-Dec-2019 | Current |
Enhance accessibility to Senmag Cell And Gene Therapy's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Senmag Cell And Gene Therapy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Subramanian Ganesan is a mutual person
Subramanian Ganesan and Senthil Ganesan are mutual person
Subramanian Ganesan is a mutual person
Subramanian Ganesan and Senthil Ganesan are mutual person
Senthil Ganesan is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Senmag Cell And Gene Therapy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Senmag Cell And Gene Therapy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Senmag Cell And Gene Therapy's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Subramanian Ganesan was appointed as a Director was appointed as a Director on 17 Dec 2019 & has been associated with this company since 5 years 2 months .
Senthil Ganesan was appointed as a Director was appointed as a Director on 17 Dec 2019 & has been associated with this company since 5 years 2 months .
Senmag Cell And Gene Therapy Private Limited was registered on 17 Dec 2019 with Roc Chennai & aged 5 years 2 months as per MCA records.
Senmag Cell And Gene Therapy Private Limited was incorporated on 17 Dec 2019.
The authorized share capital of Senmag Cell And Gene Therapy Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Currently 2 directors are associated with Senmag Cell And Gene Therapy Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Senmag Cell And Gene Therapy Private Limited is 32-3E-18 Ward No.70 Vednivas Apartments No. 52 Taylors Road, Kilpauk India, Chennai, Tamil Nadu, 600010.
The corporate identification number (CIN) of Senmag Cell And Gene Therapy Private Limited is U85100TN2019PTC133247 and the company number is 133247 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.